Double action
to counteract the
Metabolic Syndrome
Nutraceutical support with an innovative formulation, useful for controlling altered metabolic parameters such as:
Metabolic alterations are often associated with disorders such as obesity, abdominal adiposity, insulin resistance and cardiovascular risk factors.
EGREGIA contains 3 different forms of RESVERATROL, which guarantee prolonged absorption over time.
Revifast® acts on multiple levels, playing an important role in COUNTERACTING clinical signs:
RevifastlipoTM Technology
Combined with the Resveratrol Synergy from Revifast®and Alpha-Lipoic Acid, it allows for clear clinical benefits to be achieved.
Double action to counteract the Metabolic Syndrome
The Resveratrol synergy from Revifast®and Alpha-Lipoic Acid performs:
Improves glycemic parameters in women with Gestational Diabetes
The effectiveness of Egregia has been demonstrated by clinical studies conducted on: Overweight Women
Clinically tested in Pregnancy, it improves glycemic parameters in women with Established Gestational Diabetes
How to take Egregia
The recommended daily dose is to take two tablets a day for 15 days and then one tablet a day thereafter between meals.
Beneficial effects are noticeable with continuous use of the product for at least 3 months, which may be extended according to the recommendation of the medic.
